Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor canal block with ropivacaine for pain after revision knee arthroplasty
2010-021161-71Phase 4Completed
- Sponsor
- Professor Jørgen Berg Dahl
- Start
- Jun 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Ropivacaine adductor canal block with Placebo adductor canal block (2 arms). Primary endpoint: Pain score during 45-degree active knee flexion at 4 hours postoperatively. Started Jun 2010; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2010-021161-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021161-71.